Leptin and Vascular Cell Adhesion Protein 1 as Physiological Biomarkers in Serum of Women Suffering from Rheumatoid Arthritis


  • Faris Kata Department of Biology
  • Saad W. Alsulaitti Basrah General Hospital, Basrah Health Directorate, Ministry of Healthy, Basrah, Iraq
  • Muneera M. Adlan Department of Biology, College of Education for Pure Science, University of Basrah, Basrah, Iraq




Biomarkers, Leptin, Rheumatoid arthritis, Vascular cell adhesion protein 1


BACKGROUND: Rheumatoid arthritis is defining as a common chronic and inflammatory disorder of systematic autoimmune disease. Leptin is a small peptide hormone involved in the inflammatory and immunomodulators processes of several diseases.

AIM: The study aimed at evaluating the level of leptin and Vascular Cell Adhesion Protein 1 (VCAM-1) and proves that they act as vital markers in the serum of rheumatoid arthritis.

MATERIALS AND METHODS: In this study, 80 serum samples from women were obtains (56 serum samples were distributing for women with rheumatoid arthritis and 24 serum samples for uninfected women who were considered a healthy group).

RESULTS: There are no significant difference in the concentration of the leptin hormone in the serum of both patients and healthy women, and that age, period, and severity of the disease had no effect on the level of leptin hormone. However, the results confirmed that at the probability level p < 0.05 the VCAM-1 concentration increased significantly in patients’ serum when compared with the healthy group, and demonstrated that age groups only affected the VCAM-1 biomarker level.

CONCLUSIONS: Our current study concludes that leptin levels in the serum were not impacts by the inflammatory state in patients with rheumatism, whereas VCAM-1 level in rheumatic patients may be associate with inflammatory reactions.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Santhosh TR, Moin A, Gowda DV, Abhilasha TP, Lakshmeesha R, Patil NP, et al. Intra-articular drug delivery system for arthritic diseases: Overcoming the inadequacies of therapy. Indo Am J Pharm Res. 2016;6(1):4427-35. https://doi.org/10.1517/17425240802647259 PMid:19236205 DOI: https://doi.org/10.1517/17425240802647259

Weinblatt ME, Kuritzky L. RAPID: Rheumatoid arthritis. J Fam Pract. 2007;56(Suppl 4):S1-7; quiz S8. PMid:17403322

Carvalho AN, Firuzi O, Gama MJ, Horssen JV, Saso L. Oxidative stress and antioxidants in neurological diseases: Is there still hope? Curr Drug Targets. 2017;18(6):705-18. https://doi.org/10.2174/1389450117666160401120514 PMid:27033198 DOI: https://doi.org/10.2174/1389450117666160401120514

Lago F, Dieguez C, Gómez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3(12):716-24. https://doi.org/10.1038/ncprheum0674 PMid:18037931 DOI: https://doi.org/10.1038/ncprheum0674

Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001;15(14):2565-71. https://doi.org/10.1096/fj.01-0431rev PMid:11726531 DOI: https://doi.org/10.1096/fj.01-0431rev

Otero M, Lago R, Lago F, Reino JJ, Gualillo O. Signalling pathway involved in nitric oxide synthase Type II activation in chondrocytes: Synergistic effect of leptin with interleukin-1. Arthritis Res Ther. 2005;7(3):R581-91. https://doi.org/10.1186/ar1708 PMid:15899045 DOI: https://doi.org/10.1186/ar1708

Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem. 2007;14(10):1095-100. https://doi.org/10.2174/092986707780362826 PMid:17456023 DOI: https://doi.org/10.2174/092986707780362826

Golias C, Tsoutsi E, Matziridis A, Makridis P, Batistatou A, Charalabopoulos K. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo. 2007;21(5):757-69. PMid:18019409

Wong CW, Dye DE, Coombe DR. The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol. 2012;2012:340296. https://doi.org/10.1155/2012/340296 PMid:22272201 DOI: https://doi.org/10.1155/2012/340296

Sharma R, Sharma R, Khaket TP, Dutta C, Chakraborty B, Mukherjee TK. Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1. Cell Oncol (Dordr). 2017;40(3):199-208. https://doi.org/10.1007/s13402-017-0324-x PMid:28534212 DOI: https://doi.org/10.1007/s13402-017-0324-x

Allavena R, Noy S, Andrews M, Pullen N. CNS elevation of vascular and not mucosal addressin cell adhesion molecules in patients with multiple sclerosis. Am J Pathol. 2010;176(2):556-62. https://doi.org/10.2353/ajpath.2010.090437 PMid:20035048 DOI: https://doi.org/10.2353/ajpath.2010.090437

Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I, et al. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: Correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer. 2001;37(18):2392-7. https://doi.org/10.1016/s0959-8049(01)00318-5 PMid:11720833 DOI: https://doi.org/10.1016/S0959-8049(01)00318-5

Yang ZX, Han ZB, Ji YR, Wang YW, Liang L, Chi Y, et al. CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One. 2013;8(3):e59354. https://doi.org/10.1371/journal.pone.0059354 PMid:23555021 DOI: https://doi.org/10.1371/journal.pone.0059354

Folkman J. Endogenous angiogenesis inhibitors. APMIS. 2004;112(7-8):496-507. https://doi.org/10.1111/j.1600-0463.2004.apm11207-0809.x PMid:15563312 DOI: https://doi.org/10.1111/j.1600-0463.2004.apm11207-0809.x

Ding YB, Chen GY, Xia JG, Zang XW, Yang HY, Yang L. Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol. 2003;9(7):1409-14. https://doi.org/10.3748/wjg.v9.i7.1409 PMid:12854131 DOI: https://doi.org/10.3748/wjg.v9.i7.1409

Jhon RC. The ELISA Guide Book. Totowa, New Jersey: Humana Press Inc.; 2000. p. 26-8. https://doi.org/10.1385/1592590497 DOI: https://doi.org/10.1385/1592590497

Wisłowska M, Rok M, Jaszczyk B, Stepień K, Cicha M. Serum leptin in rheumatoid arthritis. Rheumatol Int. 2007;27(10):947-54. https://doi.org/10.1007/s00296-007-0335-4 PMid:17443329 DOI: https://doi.org/10.1007/s00296-007-0335-4

Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res Ther. 2006;8(5):217. https://doi.org/10.1186/ar2004 PMid:16879738 DOI: https://doi.org/10.1186/ar2004

Food and Drug Administration. Safety Update on TNF-α _Antagonists: Infliximab and Etanercept. Silver Spring, Maryland: Food and Drug Administration, Center for Biologics Evaluation and Research. Arthritis Advisory Committee Meeting; 2001.

Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis. 2005;64(8):1195-8. https://doi.org/10.1136/ard.2004.032243 PMid:15731289 DOI: https://doi.org/10.1136/ard.2004.032243

Hizmetli S, Kisa M, Gokalp N, Bakici MZ. Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int. 2007;27(4):335-8. https://doi.org/10.1007/s00296-006-0264-7 PMid:17102942 DOI: https://doi.org/10.1007/s00296-006-0264-7

Bokarewa M, Bokarew D, Hultgren O, Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(10):952-6. https://doi.org/10.1136/ard.62.10.952 PMid:12972473 DOI: https://doi.org/10.1136/ard.62.10.952

Targońska-Stepniak B, Majdan M, Dryglewska M. Leptin serum levels in rheumatoid arthritis patients: Relation to disease duration and activity. Rheumatol Int. 2008;28(6):585-91. https://doi.org/10.1007/s00296-007-0480-9 PMid:17968549 DOI: https://doi.org/10.1007/s00296-007-0480-9

Toussirot E, Grandclément E, Gaugler B, Michel F, Wendling D, Saas P, et al. Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study. Front Immunol. 2013;13(4):453. https://doi.org/10.3389/fimmu.2013.00453 PMid:24379815 DOI: https://doi.org/10.3389/fimmu.2013.00453

Tokarczyk-Knapik A, Nowicki M, Wyroślak J. The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn. 2002;108(2):761-7. PMid:12476896

Salazar-Páramo M, González-Ortiz M, González-López L, Sánchez-Ortiz A, Valera-González IC, Martínez-Abundis E, et al. Serum leptin levels in patients with rheumatoid arthritis. J Clin Rheumatol. 2001;7(1):57-9. https://doi.org/10.1097/00124743-200102000-00016 PMid:17039093 DOI: https://doi.org/10.1097/00124743-200102000-00016

Buettner R, Bollheimer LC, Zietz B, Drobnik W, Lackner K, Schmitz G, et al. Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population. J Endocrinol. 2002;175(3):745-56. https://doi.org/10.1677/joe.0.1750745 PMid:12475385 DOI: https://doi.org/10.1677/joe.0.1750745

Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M. Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South Med J. 2006;99(10):1078-83. https://doi.org/10.1097/01.smj.0000240625.27772.79 PMid:17100028 DOI: https://doi.org/10.1097/01.smj.0000240625.27772.79

Abdalla M, Effat D, Sheta M, Hamed WE. Serum leptin levels in rheumatoid arthritis and relationship with disease activity. Egypt Rheumatol. 2014;36(1):1-5. https://doi.org/10.1016/j.ejr.2013.10.002 DOI: https://doi.org/10.1016/j.ejr.2013.10.002

Mei H, Campbell JM, Paddock CM, Lertkiatmongkol P, Mosesson MW, Albrecht R, et al. Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1. J Biol Chem. 2014;289(30):20836-44. https://doi.org/10.1074/jbc.M114.557454 PMid:24936065 DOI: https://doi.org/10.1074/jbc.M114.557454

Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol. 2019;10:1078. https://doi.org/10.3389/fimmu.2019.01078 PMid:31231358 DOI: https://doi.org/10.3389/fimmu.2019.01078

Navarro-Hernández RE, Oregon-Romero E, Vázquez-Del Mercado M, Rangel-Villalobos H, Palafox-Sánchez CA, Muñoz- Valle JF. Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms. Dis Markers. 2009;26(3):119-26. https://doi.org/10.3233/DMA-2009-0621 PMid:19597294 DOI: https://doi.org/10.1155/2009/510104

Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, et al. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis. 2002;61(9):804-9. https://doi.org/10.1136/ard.61.9.804 PMid:12176805 DOI: https://doi.org/10.1136/ard.61.9.804

El-Miedany M, Ashour S, Moustafa H, Ahmed I. Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol. 2002;29(1):57-61. PMid:11824972

Wang L, Ding Y, Guo X, Zhao Q. Role and mechanism of vascular cell adhesion molecule-1 in the development of rheumatoid arthritis. Exp Ther Med. 2015;10(3):1229-1233. https://doi.org/10.3892/etm.2015.2635 PMid:26622470 DOI: https://doi.org/10.3892/etm.2015.2635

Klimek E, Skalska A, Kwaśny-Krochin B, Surdacki A, Sulicka J, Korkosz M, et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediators Inflamm. 2014;2014:681635. https://doi.org/10.1155/2014/681635 PMid:24864133 DOI: https://doi.org/10.1155/2014/681635

Smith MD, Slavotinek J, Au V, Weedon H, Parker A, Coleman M, et al. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression. Rheumatol. 2001;40(9):965-77. https://doi.org/10.1093/rheumatology/40.9.965 PMid:11561106 DOI: https://doi.org/10.1093/rheumatology/40.9.965

Blann AD, Herrick A, Jayson MI. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol. 1995;34(9):814-19. https://doi.org/10.1093/rheumatology/34.9.814 PMid:7582719 DOI: https://doi.org/10.1093/rheumatology/34.9.814




How to Cite

Kata F, Alsulaitti SW, Adlan MM. Leptin and Vascular Cell Adhesion Protein 1 as Physiological Biomarkers in Serum of Women Suffering from Rheumatoid Arthritis. Open Access Maced J Med Sci [Internet]. 2022 Jan. 19 [cited 2023 Mar. 31];10(A):164-9. Available from: https://oamjms.eu/index.php/mjms/article/view/8208





Similar Articles

You may also start an advanced similarity search for this article.